CompletedNCT01498770
How Asenapine Is Used in Bipolarity Care in the UK
About this title
Read the official source — NCT01498770Observational study
Understand this study
Study information
Study start dateStarted: April 1, 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 42
- Sponsor
- Organon and Co
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- Not clearly listed
- Official registry ID
- NCT01498770
- Official title
Show the full official title
An Observational Drug Utilization Study of SYCREST^® (Asenapine) in the United Kingdom
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Questions about this study
Who is behind this study?
The study sponsor is Organon and Co.
Did this study involve medication?
Yes. The study involved medication, including Asenapine, Aripiprazole, Quetiapine, Risperidone, Olanzapine, Ziprasidone, Iloperidone, Paliperidone, Lurasidone, Clozapine, Amisulpride, Sertindole and Zotepine.
